MX2018009847A - Metodo para preparar derivado de polietilenglicol-dialdehido. - Google Patents

Metodo para preparar derivado de polietilenglicol-dialdehido.

Info

Publication number
MX2018009847A
MX2018009847A MX2018009847A MX2018009847A MX2018009847A MX 2018009847 A MX2018009847 A MX 2018009847A MX 2018009847 A MX2018009847 A MX 2018009847A MX 2018009847 A MX2018009847 A MX 2018009847A MX 2018009847 A MX2018009847 A MX 2018009847A
Authority
MX
Mexico
Prior art keywords
polyethylene glycol
dialdehyde derivative
preparing polyethylene
glycol dialdehyde
derivative
Prior art date
Application number
MX2018009847A
Other languages
English (en)
Inventor
Rim Kim Yu
Rang Park Eun
Sung Kwon Bo
Bum Cho Young
Ho Chu Jun
Original Assignee
Hanmi Fine Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Fine Chemical Co Ltd filed Critical Hanmi Fine Chemical Co Ltd
Publication of MX2018009847A publication Critical patent/MX2018009847A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
    • C08G65/3312—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3344—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing oxygen in addition to sulfur
    • C08G65/3346—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing oxygen in addition to sulfur having sulfur bound to carbon and oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/07—Aldehydes; Ketones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)

Abstract

La presente invención se refiere a un método mejorado para preparar un derivado de polietilenglicol-dialdehído de alta pureza. El método de preparación usa, como intermediario, un PEG-diacetal preparado haciendo reaccionar metanosulfonato de polietilenglicol y un dialcoxi-1-propanol, teniendo así una ventaja de permitir la provisión de un derivado de polietilenglicol-dialdehído que tiene alta pureza y actividad de grupo terminal para que sea adecuado como material para medicinas.
MX2018009847A 2016-02-26 2017-02-21 Metodo para preparar derivado de polietilenglicol-dialdehido. MX2018009847A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160023217A KR102247701B1 (ko) 2016-02-26 2016-02-26 폴리에틸렌글리콜 디알데히드 유도체의 제조방법
PCT/KR2017/001906 WO2017146443A1 (ko) 2016-02-26 2017-02-21 폴리에틸렌글리콜 디알데히드 유도체의 제조방법

Publications (1)

Publication Number Publication Date
MX2018009847A true MX2018009847A (es) 2018-11-09

Family

ID=59686442

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009847A MX2018009847A (es) 2016-02-26 2017-02-21 Metodo para preparar derivado de polietilenglicol-dialdehido.

Country Status (10)

Country Link
US (1) US10781285B2 (es)
EP (1) EP3421521B1 (es)
JP (1) JP6927990B2 (es)
KR (1) KR102247701B1 (es)
CN (1) CN108699236B (es)
AU (1) AU2017224389A1 (es)
BR (1) BR112018067996A2 (es)
CA (1) CA3013750A1 (es)
MX (1) MX2018009847A (es)
WO (1) WO2017146443A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2019000032A1 (en) 2016-08-11 2020-07-15 Intrabio Ltd Pharmaceutical compositions and uses directed to lysosomal storage disorders
FI4001303T3 (fi) 2019-07-18 2025-07-16 Hanmi Pharmaceutical Co Ltd Menetelmä pitkävaikutteisen lääkekonjugaatin valmistamiseksi valmistamalla uudenlainen välituote
US20220273808A1 (en) * 2019-07-18 2022-09-01 Hanmi Pharm. Co., Ltd Novel method of preparing protein conjugate
KR102883648B1 (ko) * 2020-09-16 2025-11-10 한미약품 주식회사 폴리에틸렌글리콜 유도체, 이를 포함하는 조성물 및 이를 이용한 생리활성 폴리펩타이드 결합체의 제조 방법
CN115417984B (zh) * 2022-08-26 2023-07-21 厦门赛诺邦格生物科技股份有限公司 一种聚乙二醇醛衍生物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002531A (en) 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
WO2000024697A1 (en) 1998-10-26 2000-05-04 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
MXPA02003540A (es) 1999-10-08 2003-09-12 Nektar Therapeutics Al Corp Derivados de poli(etilenglicol) heterobifuncionales y los metodos para su preparacion.
MXPA05000799A (es) * 2002-07-24 2005-04-19 Hoffmann La Roche Derivados de aldehidos de polietilenglicol.
US8828373B2 (en) * 2002-11-20 2014-09-09 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance
JP5515224B2 (ja) * 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
JP5825507B2 (ja) * 2010-06-25 2015-12-02 日油株式会社 分岐型ヘテロポリエチレングリコール
US10040761B2 (en) * 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
JP6051998B2 (ja) 2012-03-30 2016-12-27 日油株式会社 マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法
JP5798100B2 (ja) * 2012-10-16 2015-10-21 信越化学工業株式会社 レジスト材料及びこれを用いたパターン形成方法
CN103834002B (zh) * 2014-02-18 2016-02-17 苏州大学 基于聚乙二醇的酸敏感性阿霉素前药及其制备方法与应用

Also Published As

Publication number Publication date
CN108699236A (zh) 2018-10-23
BR112018067996A2 (pt) 2019-01-15
JP2019507819A (ja) 2019-03-22
WO2017146443A1 (ko) 2017-08-31
AU2017224389A1 (en) 2018-10-04
EP3421521B1 (en) 2020-04-08
JP6927990B2 (ja) 2021-09-01
EP3421521A1 (en) 2019-01-02
US10781285B2 (en) 2020-09-22
EP3421521A4 (en) 2019-03-06
KR102247701B1 (ko) 2021-05-03
US20190040196A1 (en) 2019-02-07
CA3013750A1 (en) 2017-08-31
CN108699236B (zh) 2021-01-22
KR20170100842A (ko) 2017-09-05

Similar Documents

Publication Publication Date Title
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
MX385037B (es) Preparacion de 14-metil-16-oxabiciclo[10.3.1]pentadecenos de 3-metil-1,5- ciclopentadecanediona.
MX2018009847A (es) Metodo para preparar derivado de polietilenglicol-dialdehido.
WO2014141292A3 (en) Endoxifen citrate polymorph and process for preparing the same
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
WO2016105172A3 (en) A method for preparing gadobutrol
HUE058627T2 (hu) Új eljárás nagy tisztaságú prosztaglandinok elõállítására
EP4289819A3 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
IN2013MU03070A (es)
MX2017015505A (es) Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
PH12018500872A1 (en) Innovative preparation and crystallization of iosimenol
WO2014118606A3 (en) A novel process for the preparation of silodosin
FI20136028A7 (fi) Menetelmä vaahdotetun meijerituotteen valmistamiseksi
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
WO2016076573A3 (ko) 블로난세린의 제조방법 및 그를 위한 중간체
IN2013MU03508A (es)
MX361768B (es) Proceso para preparar 5-fluoro-1-metil-3-difluorometil-1h-pirazol- 4-carbaldehido.
GR1008653B (el) Μεθοδος δια την παρασκευη πιπεροναλης
IN2013MU01305A (es)
IN2013MU02595A (es)